Garrett. Heinrich, et.al., Carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice., Gastroenterology, 2010, 139

http://rdf.ncbi.nlm.nih.gov/pubmed/20381490

Garrett. Heinrich, et.al., Carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice., Gastroenterology, 2010, 139

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Ceacam2<tm1Snaj>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5314388

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased carbon dioxide production_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0008964I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• decreased fatty acid oxidation_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0014172I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• polyphagia_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0001433I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• impaired glucose tolerance_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0005293I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• increased abdominal fat pad weight_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0009286I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• abnormal glucose homeostasis_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0002078I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• increased lean body mass_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0003960I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• decreased energy expenditure_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0004890I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• increased insulin secretion_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0003058I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• obese_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0001261I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• increased circulating leptin level_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0005669I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• decreased respiratory quotient_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0010379I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• increased triglyceride level_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0005317I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• insulin resistance_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0005331I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• increased total body fat amount_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0010024I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• decreased circulating triglyceride level_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0002644I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• abnormal glycogen homeostasis_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0005438I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• increased circulating insulin level_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0002079I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• decreased oxygen consumption_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0005290I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj
• decreased muscle cell glucose uptake_Ceacam2<tm1Snaj>/Ceacam2<tm1Snaj>
  http://metadb.riken.jp/0030022I129S4SvJaeC57BL6Ceacam2tm1SnajCeacam2tm1SnajCeacam2tm1Snaj

class

http://purl.org/net/cito/citesAsAuthority

• Ceacam2<tm1Snaj>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5314388